Literature DB >> 21114488

Estradiol-dependent perforin expression by human regulatory T-cells.

Larissa Valor1, Roseta Teijeiro, Carol Aristimuño, Florence Faure, Bárbara Alonso, Clara de Andrés, Marta Tejera, Nieves López-Lazareno, Eduardo Fernández-Cruz, Silvia Sánchez-Ramón.   

Abstract

BACKGROUND: CD4+CD25+FoxP3+ regulatory T-cells (nT(Reg)) have been shown to suppress immune responses to autoantigens and to other diverse antigens, this suppression is mainly mediated by a cell contact-dependent mechanism not yet fully defined. It has been reported that both human natural and induced T(Reg) exert cytotoxic activity against autologous target cells, which suggests that the perforin/granzyme pathway may be a relevant candidate mechanism for the suppressive function of T(Reg). Previous reports have shown that oestradiol (E2) modulates T(Reg) percentages and function.
METHODS: We have evaluated in pregnant and non-pregnant subjects perforin intracellular expression in CD4+CD25+FoxP3+ regulatory T-cells by flow cytometry in whole blood, ex-vivo purified nT(Reg) and ex-vivo purified nT(Reg) after TCR and E2 stimulation. The expression of cellular degranulation markers was also phenotypically determined.
RESULTS: We show that E2 expands T(Reg), enhances in vitro T(Reg) function and induces a T(Reg) phenotype in activated responder (CD4+CD25) T-cells, further increasing the expression of perforin on T(Reg) than in vitro T-cell receptor activation alone. We found surface lysosomal-associated membrane glycoproteins (LAMP)-1 and LAMP-2 expression by T(Reg), which is a sign of cell degranulation and therefore of cytotoxicity exerted by these cells.
CONCLUSION: Our data demonstrates the presence of functional T(Reg) cytotoxic properties in biological systems and support the concept that E2 enhances the number and function of T(Reg) suggesting the potential interaction between E2 and immunoregulatory mechanisms.
© 2010 The Authors. European Journal of Clinical Investigation © 2010 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21114488     DOI: 10.1111/j.1365-2362.2010.02414.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

Review 1.  Androgen deprivation and immunotherapy for the treatment of prostate cancer.

Authors:  Melissa Gamat; Douglas G McNeel
Journal:  Endocr Relat Cancer       Date:  2017-08-16       Impact factor: 5.678

Review 2.  The T helper type 17/regulatory T cell paradigm in pregnancy.

Authors:  Ana Sofia Figueiredo; Anne Schumacher
Journal:  Immunology       Date:  2016-05       Impact factor: 7.397

Review 3.  Contribution of Adipose Tissue to Development of Cancer.

Authors:  Alyssa J Cozzo; Ashley M Fuller; Liza Makowski
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

4.  Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis.

Authors:  Carol Aristimuño; Roseta Teijeiro; Lara Valor; Bárbara Alonso; Marta Tejera-Alhambra; Clara de Andrés; Desamparados Oliver Miñarro; Nieves López-Lazareno; Florence Faure; Silvia Sánchez-Ramón
Journal:  Clin Exp Med       Date:  2012-01-07       Impact factor: 3.984

5.  Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.

Authors:  Derick Okwan-Duodu; Guillermo E Umpierrez; Otis W Brawley; Roberto Diaz
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

Review 6.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

7.  Elevated Serum Level of IL-35 Associated with the Maintenance of Maternal-Fetal Immune Tolerance in Normal Pregnancy.

Authors:  Chao-yan Yue; Bin Zhang; Chun-mei Ying
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

8.  CD4+CD25+FoxP3+ regulatory T cells and cytokines interact with estradiol in cases of missed abortion.

Authors:  Weiping Cao; Wenlin Xu; Tinmei Chen; Xiaoying Wang; Xinzhi Wang; Jian Qiu; Nintao Chen; Yu Mao
Journal:  Exp Ther Med       Date:  2013-11-25       Impact factor: 2.447

9.  Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differences.

Authors:  Marta Tejera-Alhambra; Bárbara Alonso; Roseta Teijeiro; Rocío Ramos-Medina; Carol Aristimuño; Larissa Valor; Clara De Andrés; Silvia Sánchez-Ramón
Journal:  Int J Mol Sci       Date:  2012-06-01       Impact factor: 6.208

Review 10.  The Endocrine Milieu and CD4 T-Lymphocyte Polarization during Pregnancy.

Authors:  Barbara Polese; Virginie Gridelet; Eleni Araklioti; Henri Martens; Sophie Perrier d'Hauterive; Vincent Geenen
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.